First author, year and country | Number of participants and diagnoses | Blinding | Index test criterion | Sensitivity % | Specificity % | |
---|---|---|---|---|---|---|
Huh, 2008, South Korea [54] | Total: 463, P. vivax: 144 | - | >5% pseudoeosinophilia and/or an abnormal DIFF scatter-plot† | 69.4 | 100 | |
Yoo, 2010, South Korea [55]* | Total: 1801, P. vivax: 413 | - | 46.2 | 99.7 | ||
Campuzano-Zuluaga, 2010, Colombia [51] | Total: 158, P. falciparum: 30, P. vivax: 65, 63 febrile patients Validation control group including healthy and febrile participants: 161 | + | Model ¶ | Variables (Figure 4) | ||
U-OD Pv ‡ | 'XE-2100 P. vivax pattern' | 96.9 | 93.6 | |||
M-OD Pv ** | Number of granulocyte DIFF abnormalities ≥7 pixels in the WBC/BASO(III) | 95.4 | 98.4 | |||
N-OD1 Pv | ΔDIFF/WBC Plateletcrit LYMPH-Y | 94.3 | 95.1 | |||
N-OD2 Pv | PLT-O Pixels WBC/BASO(III) | 96.8 | 96.8 | |||
N-OD1 Pf | PLT-O RDW-SD LYMPH-Y | 93 | 81 | |||
N-OD2 Pf | PLT-O RDW-SD Pixels WBC/BASO(III) | 86 | 90 |